Misplaced Pages

Docosahexaenoic acid

Names
Preferred IUPAC name (4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19-hexaenoic acid
Other names cervonic acid DHA doconexent (INN)
Identifiers
CAS Number	6217-54-5
3D model (JSmol)	Interactive image
Abbreviations	DHA
Beilstein Reference	1715505
ChEBI	CHEBI:28125
ChEMBL	ChEMBL367149
ChemSpider	393183
DrugBank	DB03756
ECHA InfoCard	100.118.398
EC Number	612-950-9
IUPHAR/BPS	1051
KEGG	C06429
PubChem CID	445580
UNII	ZAD9OKH9JC
CompTox Dashboard (EPA)	DTXSID5040465
InChI InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-Key: MBMBGCFOFBJSGT-KUBAVDMBSA-N InChI=1/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-Key: MBMBGCFOFBJSGT-KUBAVDMBBZ
SMILES O=C(O)CC\C=C/C/C=C\C\C=C/C\C=C/C\C=C/C\C=C/CC
Properties
Chemical formula	C22H32O2
Molar mass	328.488 g/mol
Density	0.943 g/cm
Melting point	−44 °C (−47 °F; 229 K)
Boiling point	446.7 °C (836.1 °F; 719.8 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is  ?) Infobox references

Docosahexaenoic acid (DHA) is an omega−3 fatty acid that is an important component of the human brain, cerebral cortex, skin, and retina. It is given the fatty acid notation 22:6(n−3). It can be synthesized from alpha-linolenic acid or obtained directly from maternal milk (breast milk), fatty fish, fish oil, or algae oil. The consumption of DHA (e.g., from fatty fish such as salmon, herring, mackerel and sardines) contributes to numerous physiological benefits, including cognition. As a component of neuronal membranes, the function of DHA is to support neuronal conduction and to allow the optimal functioning of neuronal membrane proteins (such as receptors and enzymes).

Structurally, DHA is a carboxylic acid (-oic acid) with a 22-carbon chain (docosa- derives from the Ancient Greek for 22) and six (hexa-) cis double bonds (-en-); with the first double bond located at the third carbon from the omega end. Its trivial name is cervonic acid (from the Latin word cerebrum for "brain"), its systematic name is all-cis-docosa-4,7,10,13,16,19-hexa-enoic acid.

In organisms that do not eat algae containing DHA nor animal products containing DHA, DHA is instead produced internally from α-linolenic acid, a shorter omega−3 fatty acid manufactured by plants (and also occurring in animal products as obtained from plants). Limited amounts of eicosapentaenoic and docosapentaenoic acids are possible products of α-linolenic acid metabolism in young women and men. DHA in breast milk is important for the developing infant. Rates of DHA production in women are 15% higher than in men.

DHA is a major fatty acid in brain phospholipids and the retina. Preliminary research has investigated its potential benefit in Alzheimer's disease, and cardiovascular disease, and other disorders.

Central nervous system constituent

DHA is the most abundant omega−3 fatty acid in the brain and retina. DHA comprises 40% of the polyunsaturated fatty acids (PUFAs) in the brain and 60% of the PUFAs in the retina. Fifty percent of a neuronal plasma membrane is composed of DHA. DHA modulates the carrier-mediated transport of choline, glycine, and taurine, the function of delayed rectifier potassium channels, and the response of rhodopsin contained in the synaptic vesicles.

Phosphatidylserine (PS) – which contains high DHA content – has roles in neuronal signaling and neurotransmitter synthesis, and DHA deficiency is associated with cognitive decline. DHA levels are reduced in the brain tissue of severely depressed people.

Biosynthesis

Aerobic eukaryote pathway

Aerobic eukaryotes, specifically microalgae, mosses, fungi, and some animals, perform biosynthesis of DHA as a series of desaturation and elongation reactions, catalyzed by the sequential action of desaturase and elongase enzymes. This pathway, originally identified in Thraustochytrium, applies to these groups:

1. a desaturation at the sixth carbon of alpha-linolenic acid by a delta 6 desaturase to produce stearidonic acid (SDA, 18:4 ω-3),
2. elongation of the stearidonic acid by a delta 6 elongase to produce eicosatetraenoic acid (ETA, 20:4 ω-3),
3. desaturation at the fifth carbon of eicosatetraenoic acid by a delta 5 desaturase to produce eicosapentaenoic acid (EPA, 20:5 ω-3),
4. elongation of eicosapentaenoic acid by a delta 5 elongase to produce docosapentaenoic acid (DPA, 22:5 ω-3), and
5. desaturation at the fourth carbon of docosapentaenoic acid by a delta 4 desaturase to produce DHA.

Mammals

In humans, DHA is either obtained from the diet or may be converted in small amounts from eicosapentaenoic acid (EPA, 20:5, ω-3). With the identification of FADS2 as a human Δ4-desaturase in 2015, it is now known that humans also follow the whole "aerobic eukaryote" pathway, involving Δ5-elongation to DPA and Δ4-desaturation to DHA.

A "Sprecher's shunt" hypothesis, proposed in 1991, postulates that EPA is twice elongated to 24:5 ω-3, then desaturated to 24:6 ω-3 (via delta 6 desaturase) in the mitochondria, then shortened to DHA (22:6 ω-3) via beta oxidation in the peroxisome. The hypothesis became accepted for a while because scientists have (until 2015) long tried and failed to find a Δ4-desaturase in mammals. However, the shunt model does not match clinical data, specifically as patients with beta oxidation defects do not display issues in DHA synthesis. With the identification of a Δ4-desaturase, it is considered outdated.

Anaerobic pathway

Marine bacteria and the microalgae Schizochytrium use an anerobic polyketide synthase pathway to synthesize DHA.

Metabolism

DHA can be metabolized into DHA-derived specialized pro-resolving mediators (SPMs), DHA epoxides, electrophilic oxo-derivatives (EFOX) of DHA, neuroprostanes, ethanolamines, acylglycerols, docosahexaenoyl amides of amino acids or neurotransmitters, and branched DHA esters of hydroxy fatty acids, among others.

The enzyme CYP2C9 metabolizes DHA to epoxydocosapentaenoic acids (EDPs; primarily 19,20-epoxy-eicosapentaenoic acid isomers ).

Potential health effects

Cardiovascular

Though mixed and plagued by methodological inconsistencies, there is now convincing evidence from ecological, RCTs, meta-analyses and animal trials show a benefit for omega−3 dietary intake for cardiovascular health. Of the n−3 FAs, DHA has been argued to be the most beneficial due to its preferential uptake in the myocardium, its strongly anti-inflammatory activity and its metabolism toward neuroprotectins and resolvins, the latter of which directly contribute to cardiac function.

DHA is associated with its role in cardiovascular protection and lowering the risk of coronary artery disease. DHA supplementation has been shown to improve high-density lipoprotein (‘good cholesterol’), and lower total cholesterol as well as blood pressure levels.

Pregnancy and lactation

Foods high in omega−3 fatty acids may be recommended to women who want to become pregnant or when nursing. A working group from the International Society for the Study of Fatty Acids and Lipids recommended 300 mg/day of DHA for pregnant and lactating women, whereas the average consumption was between 45 mg and 115 mg per day of the women in the study, similar to a Canadian study.

Brain and visual functions

A major structural component of the mammalian central nervous system, DHA is the most abundant omega−3 fatty acid in the brain and retina. Brain and retinal function rely on dietary intake of DHA to support a broad range of cell membrane and cell signaling properties, particularly in grey matter and retinal photoreceptor cell outer segments, which are rich in membranes.

A systematic review found that DHA had no significant benefits in improving visual field in individuals with retinitis pigmentosa. Animal research shows effect of oral intake of deuterium-reinforced DHA (D-DHA) for prevention of macular degeneration.

Asthma

Omega−3 PUFAs such as DHA and eicosapentaenoic acid (EPA) are effective in the prevention and treatment of asthma and allergic diseases.

Nutrition

Ordinary types of cooked salmon contain 500–1500 mg DHA and 300–1000 mg EPA per 100 grams. Additional rich seafood sources of DHA include caviar (3400 mg per 100 grams), anchovies (1292 mg per 100 grams), mackerel (1195 mg per 100 grams), and cooked herring (1105 mg per 100 grams).

Brains from mammals taken as food are also a good direct source. Beef brain, for example, contains approximately 855 mg of DHA per 100 grams in a serving. While DHA may be the primary fatty acid found in certain specialized tissues, these tissues, aside from the brain, are typically small in size, such as the seminiferous tubules and the retina. As a result, animal-based foods, excluding the brain, generally offer minimal amounts of preformed DHA.

Discovery of algae-based DHA

In the early 1980s, NASA sponsored scientific research on a plant-based food source that could generate oxygen and nutrition on long-duration space flights. Certain species of marine algae produced rich nutrients, leading to the development of an algae-based, vegetable-like oil that contains two polyunsaturated fatty acids, DHA and arachidonic acid.

Use as a food additive

DHA is widely used as a food supplement. It was first used primarily in infant formulas. In 2019, the US Food and Drug Administration published qualified health claims for DHA.

Some manufactured DHA is a vegetarian product extracted from algae, and it competes on the market with fish oil that contains DHA and other omega−3s such as EPA. Both fish oil and DHA are odorless and tasteless after processing as a food additive.

Studies of vegetarians and vegans

Vegetarian diets typically contain limited amounts of DHA, and vegan diets typically contain no DHA. In preliminary research, algae-based supplements increased DHA levels. While there is little evidence of adverse health or cognitive effects due to DHA deficiency in adult vegetarians or vegans, breast milk levels remain a concern for supplying adequate DHA to the infant.

DHA and EPA in fish oils

Fish oil is widely sold in capsules containing a mixture of omega−3 fatty acids, including EPA and DHA. Oxidized fish oil in supplement capsules may contain lower levels of EPA and DHA. Light, oxygen exposure, and heat can all contribute to oxidation of fish oil supplements. Buying a quality product that is kept cold in storage and then keeping it in a refrigerator can help minimize oxidation.

Recommended daily DHA intake for children

As optimal DHA level is important for brain development and maturation, there are established daily recommendations for DHA intake in children.

The table below shows the daily DHA / DHA + EPA intake recommended for children of different ages:

Experts recommend DHA intake of 10–12 mg/day for children 12–24 months, 100–150 mg/day of DHA+EPA for children 2–4 years old and 150–200 mg/day of DHA+EPA for children 4–6 years old.

See also

• DHA-clozapine
• List of omega−3 fatty acids
• Polyunsaturated fatty acids

References

1. ^ "Omega-3 fatty acids". Office of Dietary Supplements, US National Institutes of Health. 15 February 2023. Retrieved 6 March 2024.
2. Guesnet P, Alessandri JM (2011). "Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations". Biochimie. 93 (1): 7–12. doi:10.1016/j.biochi.2010.05.005. PMID 20478353.
3. Calder PC (2016). "Docosahexaenoic acid (Review)". Annals of Nutrition and Metabolism. 69 Suppl 1: 7–21. doi:10.1159/000448262. PMID 27842299.
4. Horrocks, L. A.; Yeo, Y. K. (1999). "Health benefits of docosahexaenoic acid (DHA)". Pharmacological Research. 40 (3): 211–225. doi:10.1006/phrs.1999.0495. ISSN 1043-6618. PMID 10479465.
5. Sinclair, Andrew James (2019). "Docosahexaenoic acid and the brain- what is its role?" (PDF). Asia Pacific Journal of Clinical Nutrition. 28 (4): 675–688. doi:10.6133/apjcn.201912_28(4).0002. ISSN 1440-6047. PMID 31826363.
6. "Dictionary - Definition of DocosahexaenoicAcids". Archived from the original on 2013-07-07. Retrieved 2012-04-21.
7. The omega end is the one furthest from the carboxyl group.
8. ^ Burdge, G. C.; Jones, A. E.; Wootton, S. A. (2002). "Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linolenic acid metabolism in young men". British Journal of Nutrition. 88 (4): 355–363. doi:10.1079/BJN2002662. PMID 12323085.
9. Burdge, G. C.; Wootton, S. A. (2002). "Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women". British Journal of Nutrition. 88 (4): 411–20. doi:10.1079/BJN2002689. PMID 12323090.
10. Malone, J. Patrick (2012). "The Systems Theory of Autistogenesis: Putting the Pieces Together". SAGE Open. 2 (2): 215824401244428. doi:10.1177/2158244012444281.
11. Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL (2004). "Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects". The American Journal of Clinical Nutrition. 80 (5): 1167–74. doi:10.1093/ajcn/80.5.1167. PMID 15531662.
12. Canhada S, Castro K, Perry IS, Luft VC (October 2018). "Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review". Nutritional Neuroscience. 21 (8): 529–538. doi:10.1080/1028415X.2017.1321813. PMID 28466678.
13. ^ Innes, Jacqueline; Calder, Philip (2020). "Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020". International Journal of Molecular Sciences. v (21): 1362. doi:10.3390/ijms21041362. PMC 7072971. PMID 32085487.
14. ^ Kim, Hee-Yong; Huang, Bill X.; Spector, Arthur A. (2014). "Phosphatidylserine in the brain: Metabolism and function". Progress in Lipid Research. 56: 1–18. doi:10.1016/j.plipres.2014.06.002. ISSN 0163-7827. PMC 4258547. PMID 24992464.
15. Singh, Meharban (March 2005). "Essential fatty acids, DHA and the human brain" (PDF). Indian Journal of Pediatrics. 72 (3): 239–242. doi:10.1007/BF02859265. PMID 15812120. S2CID 5067744. Archived from the original (PDF) on February 27, 2012. Retrieved October 8, 2007.
16. Spector, Arthur A.; Kim, Hee-Yong (2015). "Discovery of essential fatty acids". Journal of Lipid Research. 56 (1): 11–21. doi:10.1194/jlr.r055095. ISSN 0022-2275. PMC 4274059. PMID 25339684.
17. Spector, Arthur A. (1999). "Essentiality of fatty acids". Lipids. 34: S1–S3. doi:10.1007/BF02562220. PMID 10419080. S2CID 4061017.
18. Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (October 2005). "A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease". J Clin Invest. 115 (10): 2774–83. doi:10.1172/JCI25420. PMC 1199531. PMID 16151530.
19. McNamara RK, Hahn CG, Jandacek R, et al. (2007). "Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder". Biol. Psychiatry. 62 (1): 17–24. doi:10.1016/j.biopsych.2006.08.026. PMID 17188654. S2CID 32898004.
20. McNamara, R. K.; Jandacek, R; Tso, P; Dwivedi, Y; Ren, X; Pandey, G. N. (2013). "Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease". Journal of Psychiatric Research. 47 (9): 1187–91. doi:10.1016/j.jpsychires.2013.05.007. PMC 3710518. PMID 23759469.
21. ^ Qiu, Xiao (2003-02-01). "Biosynthesis of docosahexaenoic acid (DHA, 22:6-4, 7,10,13,16,19): two distinct pathways". Prostaglandins, Leukotrienes and Essential Fatty Acids. 68 (2): 181–186. doi:10.1016/S0952-3278(02)00268-5. ISSN 0952-3278. PMID 12538082.
22. ^ Park, HG; Park, WJ; Kothapalli, KS; Brenna, JT (September 2015). "The fatty acid desaturase 2 (FADS2) gene product catalyzes Δ4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells". FASEB Journal. 29 (9): 3911–9. doi:10.1096/fj.15-271783. PMC 4550368. PMID 26065859.
23. De Caterina, R; Basta, G (June 2001). "n-3 Fatty acids and the inflammatory response – biological background". European Heart Journal Supplements. 3 (Supplement D): D42–D49. doi:10.1016/S1520-765X(01)90118-X.
24. A Voss; M Reinhart; S Sankarappa; H Sprecher (October 1991). "The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase". The Journal of Biological Chemistry. 266 (30): 19995–20000. doi:10.1016/S0021-9258(18)54882-1. PMID 1834642. Retrieved January 2, 2011.
25. Kuda, Ondrej (2017). "Bioactive metabolites of docosahexaenoic acid". Biochimie. 136: 12–20. doi:10.1016/j.biochi.2017.01.002. PMID 28087294.
26. Westphal C, Konkel A, Schunck WH (Nov 2011). "CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?". Prostaglandins & Other Lipid Mediators. 96 (1–4): 99–108. doi:10.1016/j.prostaglandins.2011.09.001. PMID 21945326.
27. Mclennan, Peter (2014). "Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids". European Journal of Applied Physiology. 114 (7): 1333–1356. doi:10.1007/s00421-014-2876-z. PMID 24699892. S2CID 959967.
28. Horrocks, L. A.; Yeo, Y. K. (1999). "Health benefits of docosahexaenoic acid (DHA)". Pharmacological Research. 40 (3): 211–225. doi:10.1006/phrs.1999.0495. ISSN 1043-6618. PMID 10479465.
29. Harvard School Of Public Health (18 September 2012). "Omega-3 Fatty Acids: An Essential Contribution". Retrieved 12 June 2015.
30. Denomme J, Stark KD, Holub BJ (2005). "Directly quantitated dietary (n-3) fatty acid intakes of pregnant Canadian women are lower than current dietary recommendations". The Journal of Nutrition. 135 (2): 206–11. doi:10.1093/jn/135.2.206. PMID 15671214.
31. Hüppi PS (March 2008). "Nutrition for the brain: commentary on the article by Isaacs et al. on page 308" (PDF). Pediatric Research. 63 (3): 229–31. doi:10.1203/pdr.0b013e318168c6d1. PMID 18287959. S2CID 6564743.
32. Harris WS, Baack ML (January 2015). "Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity". Journal of Perinatology. 35 (1): 1–7. doi:10.1038/jp.2014.195. PMC 4281288. PMID 25357095.
33. SanGiovanni JP, Chew EY (January 2005). "The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina". Progress in Retinal and Eye Research. 24 (1): 87–138. doi:10.1016/j.preteyeres.2004.06.002. PMID 15555528. S2CID 13757616.
34. Schwartz, Stephen G.; Wang, Xue; Chavis, Pamela; Kuriyan, Ajay E.; Abariga, Samuel A. (18 June 2020). "Vitamin A and fish oils for preventing the progression of retinitis pigmentosa". The Cochrane Database of Systematic Reviews. 2020 (6): CD008428. doi:10.1002/14651858.CD008428.pub3. ISSN 1469-493X. PMC 7388842. PMID 32573764.
35. Dunaief, Joshua L. (2022). "Heavy lipids protect against heavy metals". Aging. 14 (12): 4933–4934. doi:10.18632/aging.204143. PMC 9271310. PMID 35748784.
36. Miyata, Jun; Arita, Makoto (2015). "Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases". Allergology International. 64 (1): 27–34. doi:10.1016/j.alit.2014.08.003. ISSN 1440-1592. PMID 25572556.
37. ^ "EPA and DHA Content of Fish Species. Appendix G2". US Department of Agriculture. 2005. Archived from the original on 6 October 2013. Retrieved 15 September 2013.
38. "Beef, variety meats and by-products, brain, cooked, simmered". Retrieved 2011-10-27.
39. Brenna, J. Thomas; Carlson, Susan E. (2014). "Docosahexaenoic acid and human brain development: Evidence that a dietary supply is needed for optimal development". Journal of Human Evolution. 77: 99–106. Bibcode:2014JHumE..77...99B. doi:10.1016/j.jhevol.2014.02.017. PMID 24780861.
40. Jones, John. "Nutritional Products from Space Research". May 1st, 2001. NASA. Archived from the original on 1997-06-18.
41. "FDA: Why is there interest in adding DHA and ARA to infant formulas?". US Food & Drug Administration. Retrieved 1 July 2002.
42. "FDA Announces New Qualified Health Claims for EPA and DHA Omega-3 Consumption and the Risk of Hypertension and Coronary Heart Disease". US Food and Drug Administration. 19 June 2019. Retrieved 30 August 2019.
43. Rivlin, Gary (2007-01-14). "Magical or Overrated? A Food Additive in a Swirl". The New York Times. Retrieved 2007-01-15.
44. ^ Sanders, T. A. (2009). "DHA status of vegetarians". Prostaglandins, Leukotrienes and Essential Fatty Acids. 81 (2–3): 137–41. doi:10.1016/j.plefa.2009.05.013. PMID 19500961.
45. Lane, K; Derbyshire, E; Li, W; Brennan, C (2014). "Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: A review of the literature". Critical Reviews in Food Science and Nutrition. 54 (5): 572–9. doi:10.1080/10408398.2011.596292. PMID 24261532. S2CID 30307483.
46. ^ Albert, Benjamin B (21 January 2015). "Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA release". Scientific Reports. 5: 7928. doi:10.1038/srep07928. PMC 4300506. PMID 25604397.
47. ^ Albert, Benjamin B; Cameron-Smith, David; Hofman, Paul L.; Cutfield, Wayne S. (2013). "Oxidation of Marine Omega-3 Supplements and Human Health". BioMed Research International. 2013: 464921. doi:10.1155/2013/464921. PMC 3657456. PMID 23738326.
48. Zargar, Atanaz; Ito, Matthew K. (1 August 2011). "Long chain omega-3 dietary supplements: a review of the National Library of Medicine Herbal Supplement Database". Metabolic Syndrome and Related Disorders. 9 (4): 255–271. doi:10.1089/met.2011.0004. ISSN 1557-8518. PMID 21787228.

• Fatty acids
• Alkenoic acids
• Polyenes